126 related articles for article (PubMed ID: 6303528)
21. Thrombin inhibits active sodium-potassium transport in porcine lens.
Okafor MC; Dean WL; Delamere NA
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2033-8. PubMed ID: 10440258
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of potassium on ouabain binding to native and site-directed mutants of Na,K-ATPase.
Johnson CL; Schultheis PJ; Lingrel JB; Johnson CG; Wallick ET
Arch Biochem Biophys; 1995 Feb; 317(1):133-41. PubMed ID: 7872775
[TBL] [Abstract][Full Text] [Related]
23. The steroid-binding subunit of the Na/K-ATPase as a progesterone receptor on the amphibian oocyte plasma membrane.
Morrill GA; Erlichman J; Gutierrez-Juarez R; Kostellow AB
Steroids; 2005 Dec; 70(14):933-45. PubMed ID: 16165176
[TBL] [Abstract][Full Text] [Related]
24. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
[TBL] [Abstract][Full Text] [Related]
25. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
Bagrov AY; Dmitrieva RI; Fedorova OV; Kazakov GP; Roukoyatkina NI; Shpen VM
Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
[TBL] [Abstract][Full Text] [Related]
26. Indomethacin alters the Na,K-ATPase response to protein kinase C activation in cultured rabbit nonpigmented ciliary epithelium.
Delamere NA; Parkerson J; Hou Y
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):866-75. PubMed ID: 9112982
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of the Na,K-ATPase inhibitor from hypothalamus.
Haupert GT
Prog Biochem Pharmacol; 1988; 23():10-21. PubMed ID: 2847182
[No Abstract] [Full Text] [Related]
28. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
[TBL] [Abstract][Full Text] [Related]
29. Sodium transport inhibitor from bovine hypothalamus.
Haupert GT; Sancho JM
Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4658-60. PubMed ID: 228304
[TBL] [Abstract][Full Text] [Related]
30. Palytoxin binds to and inhibits kidney and erythrocyte Na+, K+-ATPase.
Böttinger H; Habermann E
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jan; 325(1):85-7. PubMed ID: 6143267
[TBL] [Abstract][Full Text] [Related]
31. Stability of [3H]ouabain binding to the (Na+ + K+)-ATPase solubilized with C12E8.
Inaba M; Maede Y
Biochim Biophys Acta; 1985 Aug; 818(2):267-70. PubMed ID: 2992592
[TBL] [Abstract][Full Text] [Related]
32. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
[TBL] [Abstract][Full Text] [Related]
33. Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.
Tal DM; Yanuck MD; van Hall G; Karlish SJ
Biochim Biophys Acta; 1989 Oct; 985(1):55-9. PubMed ID: 2551389
[TBL] [Abstract][Full Text] [Related]
34. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
Kramer HJ; Baecker A; Weiler E; Liddiard C
Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
[TBL] [Abstract][Full Text] [Related]
35. Endogenous Na,K-ATPase inhibitor(s) and atrial natriuretic peptides: are they interrelated?
Haupert GT
Prog Biochem Pharmacol; 1988; 23():71-6. PubMed ID: 2847192
[No Abstract] [Full Text] [Related]
36. Ca-dependent inhibitor of the Na+K ATPase extracted from human red cell membranes: distinction and independence from calmodulin.
Yingst DR; Polasek DM; Marcovitz MJ
Prog Clin Biol Res; 1984; 168():127-32. PubMed ID: 6151187
[No Abstract] [Full Text] [Related]
37. An endogenous inhibitor of Na,K-ATPase isolated from human plasma inhibits the acid pump of the stomach.
Mårdh S
Prog Clin Biol Res; 1988; 268B():417-22. PubMed ID: 2851820
[No Abstract] [Full Text] [Related]
38. Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.
Akagawa K; Hara N; Tsukada Y
J Neurochem; 1984 Mar; 42(3):775-80. PubMed ID: 6319608
[TBL] [Abstract][Full Text] [Related]
39. Purification and functional characterization of a low-molecular-mass Na+, K+-ATPase inhibitor protein from rat brain cytosol.
Bhattacharyya D; Sen PC
Eur J Biochem; 1997 Mar; 244(3):829-34. PubMed ID: 9108253
[TBL] [Abstract][Full Text] [Related]
40. Na-K-ATPase: general considerations, role and regulation in the kidney.
Doucet A
Adv Nephrol Necker Hosp; 1985; 14():87-159. PubMed ID: 2579536
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
